Posts Tagged ‘ITMI’
Do You Know the Warning Signs of Bladder Cancer?
Jeanny B. Aragon-Ching, MD, is the clinical program director of genitourinary cancers at the Inova Schar Cancer Institute. She is board certified in medical oncology, hematology and internal medicine and has a special interest in caring for patients with prostate, bladder, kidney and testicular cancers. Read Dr. Aragon-Ching’s profile. (Originally published May 15, 2017) Bladder cancer…
Read MoreFDA Approves Cutting-Edge Cancer Drug from Inova Schar Cancer Institute Clinical Trial
Inova’s Dr. John Deeken served as the site principal investigator for this prestigious study In groundbreaking news for the medical and cancer research community, the Food and Drug Administration (FDA) approved a new, breakthrough cancer drug, larotrectinib, or Vitrakvi®, that targets specific genetic mutations in adult and pediatric patients. This is only the second tissue-agnostic…
Read MoreNPR Visits Inova to Document Infant-Health Research Study
Inova’s vaginal seeding study featured on NPR’s Morning Edition NPR’s Morning Edition has profiled the groundbreaking vaginal seeding study at Inova Women’s Hospital that aims to discover if babies born by C-section will benefit from a swab of their mother’s microbes. The article explains how vaginal seeding “was developed in response to the sharp rise…
Read MoreImproving the Infant Microbiome: New Inova Study Leads the Way
Suchitra K. Hourigan, MD, is board-certified in pediatrics and pediatric gastroenterology. She sees patients at Pediatric Specialists of Virginia, a medical collaboration between Inova and Children’s National. Newborn babies inherit a lot from their mothers — including beneficial bacteria that can influence their health for years to come. The human body is home to trillions…
Read MoreFor babies born by Caesarean section, can a simple swab reduce rates of obesity, asthma and allergies?
Inova clinical trial investigates outcomes of exposing newborns to mother’s microbes While Caesarean section (CS) delivery can be lifesaving for both new mothers and their babies, children born by CS have an approximately 50 percent increased risk of childhood obesity, along with asthma and allergies. There is a marked difference between the microbiomes, the community…
Read MoreConsidering New Direct-to-Consumer Breast Cancer Tests? First, Get the Facts
Tiffani A. DeMarco, MS, LCGC, is a licensed and certified genetic counselor and the manager of the cancer genetic counseling program at the Inova Translational Medicine Institute. She and her team of cancer genetic counselors specialize in counseling patients and family members at risk for hereditary cancers. The U.S. Food and Drug Administration (FDA) recently gave…
Read MoreImmunotherapy: Cancer Care Gets Customized
Timothy L. Cannon, MD, is board certified in medical oncology and hematology, and has a special interest in managing gastrointestinal cancers. Dr. Cannon is the clinical director and moderator of Inova’s weekly molecular tumor board, which matches patients with targeted therapies based on molecular diagnostics. Tiffani A. DeMarco, MS, CGC, is a board-certified…
Read MoreInova Translational Medicine Institute Deploys Cloudera Bio-IT World
Inova Translational Medicine Institute today announced that it has deployed Cloudera Enterprise to securely analyze massive collections of clinical and genomic data at unprecedented speeds and scale for faster innovations in translational medicine research. Read more.
Read MoreInova: Uncovering Breakthrough Insights that Help Save Lives Cloudera
With Cloudera Enterprise, Inova researchers can answer questions magnitudes faster than they could previously to help the organization realize its goal of delivering precision medicine. Watch more.
Read MoreTwo Va. research powerhouses come together on projects with seed fund, Washington Business Journal
Inova Health System and University of Virginia are kicking off their new partnership with $450,000 in seed money to fund nine joint research projects geared toward better predicting, preventing and treating disease. Read more.
Read More